Stock News
Lightbridge Achieves Milestone in Nuclear Technology: Co-Extrudes Uranium-Zirconium Alloy and Cladding to Produce Demonstration Sample
Lightbridge Achieves Significant Nuclear Fuel Development Milestone at Idaho National Laboratory Lightbridge Corporation, a leading advanced nuclear fuel technology company, recently announced a noteworthy accomplishment in its ongoing efforts to innovate nuclear fuel development. This milestone was marked by the successful co-extrusion of a coupon sample at Idaho National Laboratory (INL). The Co-extrusion Process The…
Boralex Announces Dividend Declaration: Detailed Information for Shareholders
Boralex Declares Eligible Quarterly Dividend: On February 12, 2025, Boralex Inc. (Boralex) announced the declaration of a quarterly dividend for its common shareholders. The dividend amount is set at $0.165 per share. Details of the Dividend: The dividend is eligible within the meaning of Section 89(14) of the Income Tax Act (Canada) and all applicable…
Aligos Therapeutics Charms Investors with $105 Million Private Placement Financing: A New Milestone in Their Biotech Journey
Exciting News from Aligos Therapeutics: $105 Million Private Placement to Fuel Phase 2 Clinical Study South San Francisco-based Aligos Therapeutics, a pioneering biotech company specializing in liver and viral diseases, recently made headlines with a significant financial development. The company announced a private placement agreement that is projected to generate approximately $105 million in gross…
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation into IIPR – Your AI Friend’s Got Your Back in Business News
Bronstein, Gewirtz & Grossman, LLC: A Class Action Lawsuit Against Innovative Industrial Properties, Inc. In the bustling city of New York, amidst the cacophony of honking taxis and chattering crowds, a significant legal development unfolded. On February 12, 2025, Bronstein, Gewirtz & Grossman, LLC, a renowned law firm, took the first step towards seeking redress…
Two Blue-Chip Stocks to Weather the Trade War Storm: Smart Picks to Shield Your Portfolio from Market Volatility
Navigating the Trade War: A Calm Investor’s Guide to Enbridge and Brookfield Asset Management Amidst the escalating trade war between the world’s largest economies, the stock market has displayed an intriguing resilience. However, the futures markets tell a different story, especially when it comes to sectors like energy and foodstuffs. In this post, we’ll discuss…
Blackbaud Empowers US Nonprofits to Accept Cryptocurrency Donations via JustGiving Platform
Blackbaud’s JustGiving Platform Now Supports Cryptocurrency Donations for US Charities In a groundbreaking move, Blackbaud, a leading software company specializing in social impact solutions, has announced the integration of cryptocurrency donations on its JustGiving platform for peer-to-peer fundraising in the United States. What Does This Mean for US Nonprofits? This new feature allows hundreds of…
WBA Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Encourages Investors to Secure Their Seats in Class Action Lawsuit Against WBA
Class Action Lawsuit Filed Against Walgreens Boots Alliance: What Does It Mean for Investors and the World? On February 12, 2025, Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, announced the filing of a class action lawsuit against Walgreens Boots Alliance, Inc. (Walgreens or the Company) and certain of its officers. The lawsuit alleges…
Intellia Therapeutics Sued for Alleged Securities Law Violations: What Does This Mean for Investors?
Understanding Your Investment Losses: A Look into the Intellia Therapeutics, Inc. (NTLA) Lawsuit Investing in the stock market can be an exciting and rewarding experience, but it also comes with inherent risks. One such risk is the possibility of suffering losses due to securities fraud or misrepresentation. Such is the case with Intellia Therapeutics, Inc….